Fig. 5From: An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitorOne-letter code amino acid sequence of the wild-type viral protein with the residues deleted to generate the variant, highlighted in red colorBack to article page